Top Markets
#1 Pleasing Gold Pleasing Gold +1,045.26%
#2 Islamic Coin Islamic Coin +154.26%
#3 PulseChain PulseChain +56.32%
#4 BOOK OF MEME BOOK OF MEME +44.02%
#5 DogBull DogBull +36.47%
#6 Ontology Gas Ontology Gas +24.72%
#7 Nockchain Nockchain +19.16%
#8 Neiro Neiro +18.85%
#9 Pump.fun Pump.fun +16.48%
#10 Unit Pump Unit Pump +16.48%
Coin of the day
Pleasing Gold Pleasing Gold
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cyfuse Biomedical K.K. Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.

4892
Classifica tra le azioni #26815
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K.... Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Prezzo delle azioni
$3.72
Capitalizzazione di mercato
$37.53M
Variazione (1 giorno)
4.78%
Variazione (1 anno)
-18.34%
Paese
JP
Scambia Cyfuse Biomedical K.K. (4892)

Categoria

Healthcare
Ricavi di Cyfuse Biomedical K.K. (4892)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Cyfuse Biomedical K.K., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Cyfuse Biomedical K.K. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH